Remote, wireless, ambulatory monitoring of implantable pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy systems: Analysis of a worldwide database

PACE - Pacing and Clinical Electrophysiology

Volumn 30, Issue SUPPL. 1, 2007, Pages

  Lazarus, Arnaud ^a,b  

^a InParys Clinical Research Associates   (France)

^b InParys Clinical Research Group   (France)

Author keywords

Ambulatory monitoring; Implantable cardiac device; Remote consultation

Indexed keywords

AMBULATORY MONITORING; ARTICLE; ARTIFICIAL HEART PACEMAKER; CARDIAC RESYNCHRONIZATION THERAPY; CAREGIVER; DEFIBRILLATOR; FOLLOW UP; HUMAN; INTERNET; MAJOR CLINICAL STUDY; TELEMONITORING; WORKLOAD;

ARRHYTHMIAS, CARDIAC; CARDIAC PACING, ARTIFICIAL; DATA COLLECTION; DATABASES, FACTUAL; DEFIBRILLATORS, IMPLANTABLE; EQUIPMENT FAILURE; HUMANS; MONITORING, PHYSIOLOGIC; PACEMAKER, ARTIFICIAL; RETROSPECTIVE STUDIES; TELEMEDICINE;

EID: 33846289600     PISSN: 01478389     EISSN: 15408159     Source Type: Journal    
DOI: 10.1111/j.1540-8159.2007.00595.x     Document Type: Article

References (25)

1. Gregoratos G, Abrams J, Epstein AE, Freedman RA, Hayes DL, Hiatky MA, Kerber RE, et al.. American College of Cardiology/American Heart Association Task Force on Practice Guidelines/North American Society for Pacing and Electrophysiology Committee to Update the 1998 Pacemaker Guidelines. ACC/AHA/NASPE 2002 guideline update for implantation of cardiac pacemakers and antiarrhythmia devices: Summary article: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/NASPE Committee to Update the 1998 Pacemaker Guidelines). Circulation 2002; 106:2145-2161.
2. Draft Recommendations Report by the Heart Rhythm Society Task Force on Device Performance Policies and Guidelines. Issued by the Heart Rhythm Society on April 26, 2006. http://www.hrsonline.org/uploadDocs/HRS.Device-Performance- Recommendations-Apr06.pdf.
3. Hauser RG, Hayes DL, Epstein AE, Cannom DS, Vlay SC, Song SL, O. Tyers GF. Multicenter experience with failed and recalled implantable cardioverter-defibrillator pulse generators. Heart Rhythm 2006; 3:640-644.
4. Hauser RG, Kallinen L. Deaths associated with implantable cardioverter defibrillator failure and deactivation reported in the United States Food and Drug Administration Manufacturer and User Facility Device Experience Database. Heart Rhythm 2004; 1:399-405.
5. Varma N, Stambler B, Chun S. Detection of atrial fibrillation by implanted devices with wireless data transmission capability. Pacing Clin Electrophysiol 2005; 28(Suppl. 1):S133-S136.
6. Stellbrink C, Hartmann A, Igidbashian D, Jaswinder G, Wunderlich E, Santini M. Home monitoring for pacemaker therapy: Intermediate results of the first European multicenter study. Pacing Clin Electrophysiol 2002; 25:686. Abstract.
7. Brugada P. What evidence do we have to replace in-hospital implantable cardioverter defibrillator follow-up? Clin Res Cardiol 2006; 95(Suppl. 3):iii3-iii9.
8. Fauchier L, Sadoul N, Kouakam C, Briand F, Chauvin M, Babuty D, Clementy J. Potential cost savings by telemedicine-assisted longterm care of implantable cardioverter defibrillator recipients. Pacing Clin Electrophysiol 2005; 28(Suppl. 1):S255-S259.
9. Ricci RP, Russo M, Santini M. Management of atrial fibrillation: What are the possibilities of early detection with Home Monitoring? Clin Res Cardiol 2006; 95(Suppl. 3):iii10-iii16.
10. Ellery S, Pakrashi T, Paul V, Sack S., On behalf of the Home CARE Phase 0 Study Investigators. Predicting mortality and rehospitalization in heart failure patients with Home Monitoring: The Home CARE pilot study. Clin Res Cardiol 2006; 95(Suppl. 3):iii29-iii35.
11. Schoenfeld MH, Compton SJ, Mead RH, Weiss DN, Sherfesee L, Englund J, Mongeon LR. Remote monitoring of implantable cardioverter defibrillators: A prospective analysis. Pacing Clin Electrophysiol 2004; 27:757-763.
12. Fetsch T, Bauer P, Engberding R, Koch HP, Lukl J, Meinertz T, Oeff M, et al. Prevention of Atrial Fibrillation after Cardioversion Investigators. Prevention of atrial fibrillation after cardioversion: Results of the PAFAC trial. Eur Heart J 2004; 25:1385-1394.
13. Klemm HU, Ventura R, Rostock T, Brandstrup B, Risius T, Meinertz T, Willems S. Correlation of symptoms to ECG diagnosis following atrial fibrillation ablation. J Cardiovasc Electrophysiol 2006; 17:146-150.
14. Hindricks G, Piorkowski C, Tanner H, Kobza R, Gerds-Li JH, Carbucicchio C, Kottkamp H. Perception of atrial fibrillation before and after radiofrequency catheter ablation: Relevance of asymptomatic arrhythmia recurrence. Circulation 2005; 112:307-313.
15. Page RL, Wilkinson WE, Clair WK, McCarthy EA, Pritchett EL. Asymptomatic arrhythmias in patients with symptomatic paroxysmal atrial fibrillation and paroxysmal supraventricular tachycardia. Circulation 1994; 89:224-227.
16. Oral H, Veerareddy S, Good E, Hall B, Cheung P, Tamirisa K, Han J, et al. Prevalence of asymptomatic recurrences of atrial fibrillation after successful radiofrequency catheter ablation. J Cardiovascular Electrophysiol 2004; 15:920-924.
17. Callans D. Asymptomatic atrial fibrillation in symptomatic patients. J Cardiovasc Electrophysiol 2004; 15:925-926.
18. de Lusignan S, Wells S, Johnson P, Meredith K, Leatham E. Compliance and effectiveness of 1 year's home telemonitoring the report of a pilot study of patients with chronic heart failure. Eur J Heart Fail 2001; 3:723-730.
19. Riegel B, Carlson B, Kopp Z, LePetri B, Glaser D, Unger A. Effect of a standardized nurse case-management telephone intervention on resource use in patients with chronic heart failure. Arch Intern Med 2002; 162:705-712.
20. Goldberg LR, Piette JD, Walsh MN, et al. WHARF Investigators. Randomized trial of a daily electronic home monitoring system in patients with advanced heart failure: The Weight Monitoring in Heart Failure (WHARF) trial. Am Heart J 2003; 146:705-712.
21. Cleland JG, Louis AA, Rigby AS, Janssens U, Balk AH., On behalf of the TEN-HMS Investigators. Noninvasive home telemonitoring for patients with heart failure at high risk of recurrent admission and death. The Trans-European Network-Home-Care Management System (TEN-HMS) Study. J Am Coll Cardiol 2005; 45:1654-1664.
22. Louis AA, Turner T, Gretton M, Baksh A, Cleland JG. A systematic review of telemonitoring for the management of heart failure. Eur J Heart Fail 2003; 5:583-590.
23. Opasich C, Rapezzi C, Lucci D, Gorini M, Pozzar F, Zanelli E, Tavazzi L, et al. Italian Network on Congestive Heart Failure (INCHF) Investigators. Precipitating factors and decision-making processes of short-term worsening heart failure despite "optimal" treatment (from the IN-CHF Registry). Am J Cardiol 2001; 88:382-387.
24. Aaronson KD, Schwartz JS, Chen TM, Wong KL, Goin JE, Mancini DM. Development and prospective validation of a clinical index to predict survival in ambulatory patients referred for cardiac transplant evaluation. Circulation 1997; 95:2660-2667.
25. Pocock SJ, Wang D, Pfeffer MA, Yusuf S, McMurray JJ, Swedborg KB, Ostergren J, et al. Predictors of mortality and morbidity in patients with chronic heart failure. Eur Heart J 2006; 27:65-75.